| scholarly article | Q13442814 |
| P2093 | author name string | Shaili Shah | |
| Eveline Wu | |||
| Teresa K. Tarrant | |||
| V. Koneti Rao | |||
| P2860 | cites work | Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II | Q22010404 |
| Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome | Q24623046 | ||
| Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop | Q24632569 | ||
| How I treat autoimmune lymphoproliferative syndrome | Q24633207 | ||
| Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS) | Q24643047 | ||
| Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome | Q24650472 | ||
| Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS) | Q24685850 | ||
| A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation | Q28246980 | ||
| Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis | Q28299956 | ||
| Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study | Q33366703 | ||
| Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene | Q33376403 | ||
| Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome | Q33394927 | ||
| Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome | Q33396299 | ||
| Rituximab for children with immune thrombocytopenia: a systematic review | Q33401605 | ||
| Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation. | Q33500292 | ||
| Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease | Q33818169 | ||
| The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis | Q33952333 | ||
| Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation | Q34428954 | ||
| Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes | Q35840445 | ||
| A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. | Q36454970 | ||
| Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults | Q36862333 | ||
| Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations | Q37670054 | ||
| Autoimmune lymphoproliferative disorder in an adult patient | Q40322441 | ||
| Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome | Q40323055 | ||
| Autoimmune lymphoproliferative syndrome: response to mycophenolate mofetil and pyrimethamine/sulfadoxine in a 5-year-old child | Q42810256 | ||
| IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. | Q45115236 | ||
| The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood. | Q55038036 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation | Q57078461 | ||
| Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome | Q59291525 | ||
| Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion | Q61053488 | ||
| Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation | Q77169432 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune lymphoproliferative syndrome | Q1151300 |
| P304 | page(s) | 462 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Current Allergy and Asthma Reports | Q2246111 |
| P1476 | title | Autoimmune lymphoproliferative syndrome: an update and review of the literature | |
| P478 | volume | 14 |
| Q33824362 | A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination |
| Q55297581 | Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation. |
| Q47151016 | Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. |
| Q49644376 | Autoimmunity and primary immunodeficiency: two sides of the same coin? |
| Q26742072 | Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency |
| Q64059809 | Case report of a molar-root incisor malformation in a patient with an autoimmune lymphoproliferative syndrome |
| Q38630748 | Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society o |
| Q39251222 | Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance. |
| Q90401134 | Flow Cytometry for Diagnosis of Primary Immune Deficiencies-A Tertiary Center Experience From North India |
| Q38554722 | Human autoimmune diseases: a comprehensive update |
| Q36236807 | Immunogenetics of systemic lupus erythematosus: A comprehensive review |
| Q64109685 | Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice |
| Q52571131 | Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome. |
| Q90252292 | Primary immunodeficiencies and their associated risk of malignancies in children: an overview |
| Q40202981 | T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing. |
| Q57078448 | The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions |
| Q36302763 | Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice |
| Q33420245 | Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS). |
Search more.